Pulmonology

Vapendavir shows promise in reducing respiratory symptoms and illness duration in COPD patients infected with rhinovirus.

Long-term studies reveal that benralizumab achieves sustained remission in severe eosinophilic asthma, significantly reducing exacerbations in older adults.

New research follows a previous landmark study that linked mucus plugs to increased mortality in people with COPD even without hallmark symptoms.

View slated interviews with experts and 7 clinical trials to watch at ATS 2025.

This month’s Lungcast features a discussion on the ALA’s State of the Air report and how worsening air conditions affect people across the nation.

Explore innovative strategies for asthma management that prioritize shared decision-making and address environmental, social, and behavioral factors.

A recent study reveals that asthma-COPD overlap does not significantly worsen outcomes in well-managed severe asthma patients.

The asthma-related emergency department visits highlighted here, following the Canadian wildfires near Ontario, were attributed to smoke inhalation.

XGBoost displayed a high rate of accuracy, sensitivity, and precision, indicating its effectiveness at highlighting depressive symptoms before diagnosis.

New findings reveal that higher HbA1c levels worsen asthma control in children, linking metabolic dysfunction to increased asthma morbidity.

These data suggest that heart health, as determined by the LC9 assessment, is positively correlated with pulmonary health.

A variety of influences and potential confounders exist to explain the increasing rates of impairment concordant with chronic obstructive pulmonary disease.

Virtual pulmonary rehabilitation enhances access and improves outcomes for COPD patients, demonstrating safety and effectiveness in individualized care.

New research reveals Medicaid unwinding disrupts chronic medication access for young adults, risking health and treatment outcomes amid enrollment losses.

AI enhances prediction, diagnosis, and treatment of allergic diseases including asthma, atopic dermatitis, and food allergies, offering personalized, efficient care.

New triple therapy BGF shows significant and clinically meaningful lung function improvement in patients with uncontrolled asthma, with full data readouts coming soon.

The month in review spotlights new data for COPD and bronchiectasis, as well as new research and conversations around smoking.

New research links high smoke pollution to increased respiratory hospitalizations in older adults, highlighting urgent health risks from wildfires.

Mepolizumab significantly reduces COPD exacerbations in patients with eosinophilic phenotype, offering new hope for improved management and patient outcomes.

The 25-mg brensocatib group showed statistically significant changes in FEV1 decline as well as pulmonary exacerbations.

1 in 5 patients were incompletely screened for CFLD based on 2023 guidelines, with Hispanic ethnicity and public insurance linked to an increased risk.

This month’s Lungcast features a discussion on lung cancer screening guidelines and pulmonary nodule management.

Participants in the cytisinicline group also had a significantly greater reduction in smoking urges.

Overall, Asthma Control Test (ACT) measures improved by 37%.

In this summary, we highlight the latest issue of our pulmonology research quarterly newsletter powered by the American Lung Association Research Institute.